

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.47475870 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.47475870 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.12926889 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.12926889 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.72251472 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22718613 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.17100452 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.17100452 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.17100452 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.05863536 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.76337015 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.76171884 |
| 13 | intestinal absorption (GO:0050892) | 5.63785387 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.62726961 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.61441534 |
| 16 | urea cycle (GO:0000050) | 5.53390499 |
| 17 | urea metabolic process (GO:0019627) | 5.53390499 |
| 18 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.43800193 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.38463089 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.30893966 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.30654468 |
| 22 | cysteine metabolic process (GO:0006534) | 5.22517200 |
| 23 | protein-lipid complex subunit organization (GO:0071825) | 5.18667588 |
| 24 | protein carboxylation (GO:0018214) | 5.16729553 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.16729553 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.15822428 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.12880054 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.07935488 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.04982820 |
| 30 | bile acid metabolic process (GO:0008206) | 5.01221431 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.93110305 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.85996548 |
| 33 | regulation of apoptotic cell clearance (GO:2000425) | 4.78068667 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.77962753 |
| 35 | regulation of complement activation (GO:0030449) | 4.77543354 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.76494287 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.72220150 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.72007749 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.69791405 |
| 40 | negative regulation of cholesterol transport (GO:0032375) | 4.66809775 |
| 41 | negative regulation of sterol transport (GO:0032372) | 4.66809775 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.64689836 |
| 43 | regulation of plasminogen activation (GO:0010755) | 4.62256184 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.61104860 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.61104860 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.61104860 |
| 47 | triglyceride homeostasis (GO:0070328) | 4.58661523 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.58661523 |
| 49 | phospholipid efflux (GO:0033700) | 4.54342564 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.53198059 |
| 51 | cellular ketone body metabolic process (GO:0046950) | 4.52893675 |
| 52 | bile acid and bile salt transport (GO:0015721) | 4.52405085 |
| 53 | lysine catabolic process (GO:0006554) | 4.50875863 |
| 54 | lysine metabolic process (GO:0006553) | 4.50875863 |
| 55 | diacylglycerol metabolic process (GO:0046339) | 4.49010115 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.42970694 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.41005287 |
| 58 | glutamate metabolic process (GO:0006536) | 4.39229525 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.35039161 |
| 60 | drug catabolic process (GO:0042737) | 4.31829504 |
| 61 | imidazole-containing compound metabolic process (GO:0052803) | 4.31638550 |
| 62 | proline metabolic process (GO:0006560) | 4.30031812 |
| 63 | epoxygenase P450 pathway (GO:0019373) | 4.23103523 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 4.23068521 |
| 65 | amine catabolic process (GO:0009310) | 4.23068521 |
| 66 | cellular glucuronidation (GO:0052695) | 4.21824868 |
| 67 | cholesterol efflux (GO:0033344) | 4.21431802 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 4.19395315 |
| 69 | lipoprotein metabolic process (GO:0042157) | 4.15569324 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 4.13898966 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 4.13363883 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 4.12901542 |
| 73 | regulation of cholesterol homeostasis (GO:2000188) | 4.09822651 |
| 74 | regulation of bile acid biosynthetic process (GO:0070857) | 4.09161081 |
| 75 | glycine metabolic process (GO:0006544) | 4.07786407 |
| 76 | ethanol oxidation (GO:0006069) | 4.04022363 |
| 77 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.03091744 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02981737 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 3.97889766 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.95459924 |
| 81 | arginine metabolic process (GO:0006525) | 3.93938532 |
| 82 | ketone body metabolic process (GO:1902224) | 3.91525224 |
| 83 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.85318324 |
| 84 | fibrinolysis (GO:0042730) | 3.79473435 |
| 85 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.79270019 |
| 86 | intestinal cholesterol absorption (GO:0030299) | 3.77010845 |
| 87 | low-density lipoprotein particle remodeling (GO:0034374) | 3.76824991 |
| 88 | serine family amino acid biosynthetic process (GO:0009070) | 3.76387705 |
| 89 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75686903 |
| 90 | phospholipid homeostasis (GO:0055091) | 3.75331684 |
| 91 | cholesterol homeostasis (GO:0042632) | 3.74058490 |
| 92 | negative regulation of blood coagulation (GO:0030195) | 3.73932194 |
| 93 | negative regulation of hemostasis (GO:1900047) | 3.73932194 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.73649433 |
| 95 | glucuronate metabolic process (GO:0019585) | 3.73649433 |
| 96 | negative regulation of protein activation cascade (GO:2000258) | 3.71024048 |
| 97 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69971320 |
| 98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69971320 |
| 99 | short-chain fatty acid metabolic process (GO:0046459) | 3.68919764 |
| 100 | sterol homeostasis (GO:0055092) | 3.68578252 |
| 101 | exogenous drug catabolic process (GO:0042738) | 3.67644063 |
| 102 | acetyl-CoA metabolic process (GO:0006084) | 3.66653452 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.65133655 |
| 104 | organic acid catabolic process (GO:0016054) | 3.63560183 |
| 105 | carboxylic acid catabolic process (GO:0046395) | 3.63560183 |
| 106 | complement activation, classical pathway (GO:0006958) | 3.63139797 |
| 107 | flavonoid metabolic process (GO:0009812) | 3.62369535 |
| 108 | cofactor catabolic process (GO:0051187) | 3.62093849 |
| 109 | negative regulation of lipase activity (GO:0060192) | 3.62081359 |
| 110 | aldehyde catabolic process (GO:0046185) | 3.61509244 |
| 111 | regulation of cholesterol metabolic process (GO:0090181) | 3.58635694 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.58377998 |
| 113 | positive regulation of steroid metabolic process (GO:0045940) | 3.57577826 |
| 114 | sterol transport (GO:0015918) | 3.57352731 |
| 115 | cholesterol transport (GO:0030301) | 3.57352731 |
| 116 | complement activation (GO:0006956) | 3.55483493 |
| 117 | blood coagulation, intrinsic pathway (GO:0007597) | 3.54957335 |
| 118 | acute-phase response (GO:0006953) | 3.53732832 |
| 119 | plasma lipoprotein particle organization (GO:0071827) | 3.53034425 |
| 120 | protein activation cascade (GO:0072376) | 3.52777096 |
| 121 | ethanol metabolic process (GO:0006067) | 3.51733470 |
| 122 | negative regulation of coagulation (GO:0050819) | 3.46872142 |
| 123 | angiotensin maturation (GO:0002003) | 3.45612722 |
| 124 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.40381008 |
| 125 | proline biosynthetic process (GO:0006561) | 3.31150728 |
| 126 | lipoprotein transport (GO:0042953) | 3.31019822 |
| 127 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.27709015 |
| 128 | negative regulation of wound healing (GO:0061045) | 3.26719537 |
| 129 | regulation of humoral immune response (GO:0002920) | 3.25282384 |
| 130 | lipid homeostasis (GO:0055088) | 3.24505947 |
| 131 | lung epithelium development (GO:0060428) | 3.23846837 |
| 132 | positive regulation of blood coagulation (GO:0030194) | 3.23453391 |
| 133 | positive regulation of hemostasis (GO:1900048) | 3.23453391 |
| 134 | positive regulation of extracellular matrix organization (GO:1903055) | 3.22779870 |
| 135 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.21429471 |
| 136 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.17411050 |
| 137 | drug transmembrane transport (GO:0006855) | 3.09655168 |
| 138 | vitamin transmembrane transport (GO:0035461) | 3.09303292 |
| 139 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.07117406 |
| 140 | positive regulation of coagulation (GO:0050820) | 2.99555269 |
| 141 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.98955056 |
| 142 | endocrine process (GO:0050886) | 2.98955056 |
| 143 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.98955056 |
| 144 | regulation of extracellular matrix organization (GO:1903053) | 2.98397130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.92134280 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.81551231 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.29741650 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.20625384 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.08273189 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.42251935 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.32971984 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98483544 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.41596317 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.92896908 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.74517829 |
| 12 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0954117 |
| 13 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.94160220 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.86353606 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.82504264 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.69432267 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55898832 |
| 18 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.51062607 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48769015 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.48447309 |
| 21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.46216869 |
| 22 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42435554 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42223573 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40690858 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.27338141 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19635447 |
| 27 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17576527 |
| 28 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.16902892 |
| 29 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14678198 |
| 30 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.14506359 |
| 31 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13236088 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11248239 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08320916 |
| 34 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07093282 |
| 35 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06606163 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03727092 |
| 37 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03296256 |
| 38 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02081506 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01931934 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01507576 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.01068655 |
| 42 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00942100 |
| 43 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99635490 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99067935 |
| 45 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98771926 |
| 46 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98071466 |
| 47 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97916751 |
| 48 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96716698 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96542912 |
| 50 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.96390680 |
| 51 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.96378946 |
| 52 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96254877 |
| 53 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95862270 |
| 54 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94928229 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94892604 |
| 56 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94231887 |
| 57 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.93730601 |
| 58 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93524808 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93426671 |
| 60 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91528694 |
| 61 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.89453369 |
| 62 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89006808 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88875570 |
| 64 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88061932 |
| 65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85931688 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85818063 |
| 67 | * P68_20966046_ChIP-Seq_HELA_Human | 0.85013457 |
| 68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84860999 |
| 69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84436236 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84253539 |
| 71 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.83688931 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.83273389 |
| 73 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82261164 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.82013305 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79059050 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78041907 |
| 77 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78026640 |
| 78 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77224044 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76299169 |
| 80 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.74948236 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.74689006 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.73047376 |
| 83 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72227217 |
| 84 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.70326978 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 0.70298750 |
| 86 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69996431 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.69119841 |
| 88 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69077657 |
| 89 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67665629 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.67580481 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66203167 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66203167 |
| 93 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.65311007 |
| 94 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65287652 |
| 95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64319329 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.63061229 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.62332059 |
| 98 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.57489790 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.57480318 |
| 100 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57363494 |
| 101 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.56860683 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56778048 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.56181252 |
| 104 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.56153516 |
| 105 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55388112 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54295946 |
| 107 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.53069899 |
| 108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.52401454 |
| 109 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52184992 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51694929 |
| 111 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50794775 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.50784241 |
| 113 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.50625890 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.49991455 |
| 115 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49623801 |
| 116 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49424655 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.48330461 |
| 118 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.47781735 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.47629891 |
| 120 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47123017 |
| 121 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47053741 |
| 122 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.45794746 |
| 123 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45497054 |
| 124 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45489343 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.45445961 |
| 126 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.44844284 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44712981 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.44650707 |
| 129 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44275197 |
| 130 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.44234465 |
| 131 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.44207272 |
| 132 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44002614 |
| 133 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.42576812 |
| 134 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.42076644 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41899045 |
| 136 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.41818526 |
| 137 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41600215 |
| 138 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40818048 |
| 139 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40281286 |
| 140 | NCOR_22424771_ChIP-Seq_293T_Human | 0.39547624 |
| 141 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.39144491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.31485380 |
| 2 | MP0005360_urolithiasis | 7.81364692 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.49182507 |
| 4 | MP0005365_abnormal_bile_salt | 6.10868995 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.18345253 |
| 6 | MP0003252_abnormal_bile_duct | 4.05582619 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.92597122 |
| 8 | MP0003122_maternal_imprinting | 3.91276854 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.62565596 |
| 10 | MP0000566_synostosis | 3.17943460 |
| 11 | MP0009840_abnormal_foam_cell | 3.16798906 |
| 12 | MP0005083_abnormal_biliary_tract | 3.05731437 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.90913322 |
| 14 | MP0003195_calcinosis | 2.72051056 |
| 15 | MP0005332_abnormal_amino_acid | 2.71825459 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.22214203 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.20003448 |
| 18 | MP0002089_abnormal_postnatal_growth/wei | 2.12855201 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.11461262 |
| 20 | MP0000609_abnormal_liver_physiology | 2.08747216 |
| 21 | MP0003123_paternal_imprinting | 2.07458967 |
| 22 | MP0005409_darkened_coat_color | 1.99646643 |
| 23 | MP0003868_abnormal_feces_composition | 1.95069505 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.81812967 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.76233469 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.73558637 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.54341761 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51956579 |
| 29 | MP0001764_abnormal_homeostasis | 1.48433084 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.47911459 |
| 31 | MP0005451_abnormal_body_composition | 1.35973774 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.35263842 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.33286754 |
| 34 | MP0009697_abnormal_copulation | 1.32480134 |
| 35 | MP0003879_abnormal_hair_cell | 1.28514769 |
| 36 | MP0005257_abnormal_intraocular_pressure | 1.28082321 |
| 37 | MP0002132_abnormal_respiratory_system | 1.26189911 |
| 38 | MP0003011_delayed_dark_adaptation | 1.24826300 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.21336095 |
| 40 | MP0001915_intracranial_hemorrhage | 1.16397993 |
| 41 | MP0000604_amyloidosis | 1.12781543 |
| 42 | MP0005647_abnormal_sex_gland | 1.09638440 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.09218881 |
| 44 | MP0002254_reproductive_system_inflammat | 1.06438927 |
| 45 | MP0000598_abnormal_liver_morphology | 1.04913591 |
| 46 | MP0004272_abnormal_basement_membrane | 0.99631254 |
| 47 | MP0003315_abnormal_perineum_morphology | 0.98423399 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 0.95725124 |
| 49 | MP0005076_abnormal_cell_differentiation | 0.94213340 |
| 50 | MP0009764_decreased_sensitivity_to | 0.94193956 |
| 51 | MP0000678_abnormal_parathyroid_gland | 0.93353992 |
| 52 | MP0003121_genomic_imprinting | 0.92470192 |
| 53 | MP0004270_analgesia | 0.90836459 |
| 54 | MP0002822_catalepsy | 0.87877046 |
| 55 | MP0003567_abnormal_fetal_cardiomyocyte | 0.87437409 |
| 56 | MP0010368_abnormal_lymphatic_system | 0.87196907 |
| 57 | MP0003329_amyloid_beta_deposits | 0.85921643 |
| 58 | MP0009763_increased_sensitivity_to | 0.84675746 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 0.84477399 |
| 60 | MP0003186_abnormal_redox_activity | 0.84042855 |
| 61 | MP0009642_abnormal_blood_homeostasis | 0.84017956 |
| 62 | MP0003115_abnormal_respiratory_system | 0.81792982 |
| 63 | MP0002249_abnormal_larynx_morphology | 0.80622356 |
| 64 | MP0009053_abnormal_anal_canal | 0.79804370 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.79759342 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 0.76521208 |
| 67 | MP0003690_abnormal_glial_cell | 0.72345651 |
| 68 | MP0003942_abnormal_urinary_system | 0.72113106 |
| 69 | MP0005408_hypopigmentation | 0.71987075 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 0.71406295 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 0.70623424 |
| 72 | MP0008469_abnormal_protein_level | 0.70054314 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 0.68512619 |
| 74 | MP0002971_abnormal_brown_adipose | 0.68483793 |
| 75 | MP0005535_abnormal_body_temperature | 0.68301264 |
| 76 | MP0004858_abnormal_nervous_system | 0.68147146 |
| 77 | MP0002909_abnormal_adrenal_gland | 0.68090901 |
| 78 | MP0000477_abnormal_intestine_morphology | 0.67713312 |
| 79 | MP0001664_abnormal_digestion | 0.67706093 |
| 80 | MP0005334_abnormal_fat_pad | 0.66355218 |
| 81 | MP0005448_abnormal_energy_balance | 0.65177473 |
| 82 | MP0001756_abnormal_urination | 0.63400353 |
| 83 | MP0001270_distended_abdomen | 0.63130959 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 0.62778982 |
| 85 | MP0010234_abnormal_vibrissa_follicle | 0.62766073 |
| 86 | MP0004130_abnormal_muscle_cell | 0.62042451 |
| 87 | MP0005266_abnormal_metabolism | 0.59666319 |
| 88 | MP0000639_abnormal_adrenal_gland | 0.59041364 |
| 89 | MP0000534_abnormal_ureter_morphology | 0.58205610 |
| 90 | MP0003878_abnormal_ear_physiology | 0.57605145 |
| 91 | MP0005377_hearing/vestibular/ear_phenot | 0.57605145 |
| 92 | MP0005670_abnormal_white_adipose | 0.57595697 |
| 93 | MP0003866_abnormal_defecation | 0.56058813 |
| 94 | MP0001661_extended_life_span | 0.54329406 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.54176758 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.53776559 |
| 97 | MP0000579_abnormal_nail_morphology | 0.52755952 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.52289923 |
| 99 | MP0002938_white_spotting | 0.52259691 |
| 100 | MP0008872_abnormal_physiological_respon | 0.51889377 |
| 101 | MP0004264_abnormal_extraembryonic_tissu | 0.51451661 |
| 102 | MP0003943_abnormal_hepatobiliary_system | 0.50730413 |
| 103 | MP0008874_decreased_physiological_sensi | 0.49278468 |
| 104 | MP0003638_abnormal_response/metabolism_ | 0.48443076 |
| 105 | MP0002896_abnormal_bone_mineralization | 0.47950258 |
| 106 | MP0002928_abnormal_bile_duct | 0.46651252 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.46205341 |
| 108 | MP0003953_abnormal_hormone_level | 0.45709229 |
| 109 | MP0003632_abnormal_nervous_system | 0.45226452 |
| 110 | MP0006054_spinal_hemorrhage | 0.44730237 |
| 111 | MP0005187_abnormal_penis_morphology | 0.44653636 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.43865260 |
| 113 | MP0005166_decreased_susceptibility_to | 0.43760399 |
| 114 | MP0002796_impaired_skin_barrier | 0.42661898 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.41756876 |
| 116 | MP0002233_abnormal_nose_morphology | 0.41524617 |
| 117 | MP0005395_other_phenotype | 0.40520629 |
| 118 | MP0003941_abnormal_skin_development | 0.39322778 |
| 119 | MP0001849_ear_inflammation | 0.39035588 |
| 120 | MP0002092_abnormal_eye_morphology | 0.38984217 |
| 121 | MP0003119_abnormal_digestive_system | 0.37777218 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.37350359 |
| 123 | MP0003075_altered_response_to | 0.36704323 |
| 124 | MP0008873_increased_physiological_sensi | 0.36650761 |
| 125 | MP0003718_maternal_effect | 0.36250407 |
| 126 | MP0009672_abnormal_birth_weight | 0.35399487 |
| 127 | MP0002697_abnormal_eye_size | 0.34997116 |
| 128 | MP0000920_abnormal_myelination | 0.34973963 |
| 129 | MP0005167_abnormal_blood-brain_barrier | 0.34814085 |
| 130 | MP0000538_abnormal_urinary_bladder | 0.34589884 |
| 131 | MP0004043_abnormal_pH_regulation | 0.34462736 |
| 132 | MP0005464_abnormal_platelet_physiology | 0.34294651 |
| 133 | MP0000230_abnormal_systemic_arterial | 0.33321403 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.29131724 |
| 135 | MP0002090_abnormal_vision | 0.28314493 |
| 136 | MP0002837_dystrophic_cardiac_calcinosis | 0.27713876 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.27038646 |
| 138 | MP0004381_abnormal_hair_follicle | 0.26944819 |
| 139 | MP0002168_other_aberrant_phenotype | 0.26402430 |
| 140 | MP0002069_abnormal_eating/drinking_beha | 0.26047509 |
| 141 | MP0009115_abnormal_fat_cell | 0.25372945 |
| 142 | MP0004883_abnormal_blood_vessel | 0.25369367 |
| 143 | MP0002970_abnormal_white_adipose | 0.24595140 |
| 144 | MP0000467_abnormal_esophagus_morphology | 0.22201418 |
| 145 | MP0001881_abnormal_mammary_gland | 0.21933254 |
| 146 | MP0000427_abnormal_hair_cycle | 0.21597824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.32038489 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.31924053 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.28088242 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64372098 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.42175324 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.38807740 |
| 7 | Xanthomatosis (HP:0000991) | 6.18903644 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.39588778 |
| 9 | Complement deficiency (HP:0004431) | 5.28746271 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.73670249 |
| 11 | Epidermoid cyst (HP:0200040) | 4.61623976 |
| 12 | Hyperammonemia (HP:0001987) | 4.53564686 |
| 13 | Joint hemorrhage (HP:0005261) | 4.50800259 |
| 14 | Hyperglycinemia (HP:0002154) | 4.48852827 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.33295590 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.27088608 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.25750189 |
| 18 | Ketosis (HP:0001946) | 4.25032967 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16574603 |
| 20 | Fat malabsorption (HP:0002630) | 4.15242692 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.09010485 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 4.05368908 |
| 23 | Hyperglycinuria (HP:0003108) | 4.00356484 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.99400807 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99400807 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.96828651 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.90259464 |
| 28 | Abnormality of complement system (HP:0005339) | 3.80263843 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.62998772 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.60752760 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.52767114 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.52074053 |
| 33 | Flat acetabular roof (HP:0003180) | 3.43711383 |
| 34 | Abnormality of carpal bone ossification (HP:0006257) | 3.37031682 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.32722247 |
| 36 | Abnormal tarsal ossification (HP:0008369) | 3.23242652 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.18531609 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.11748208 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.11304179 |
| 40 | Spontaneous abortion (HP:0005268) | 3.09014937 |
| 41 | Ketoacidosis (HP:0001993) | 3.07200505 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.00095400 |
| 43 | Steatorrhea (HP:0002570) | 2.96642164 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.95792723 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.95098952 |
| 46 | Myocardial infarction (HP:0001658) | 2.90081813 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 2.86123857 |
| 48 | Skin nodule (HP:0200036) | 2.74956565 |
| 49 | Metabolic acidosis (HP:0001942) | 2.74135152 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.74106073 |
| 51 | Broad alveolar ridges (HP:0000187) | 2.68927456 |
| 52 | Acanthocytosis (HP:0001927) | 2.68518576 |
| 53 | Vascular calcification (HP:0004934) | 2.68127965 |
| 54 | Malnutrition (HP:0004395) | 2.66936736 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.66221461 |
| 56 | Widely patent fontanelles and sutures (HP:0004492) | 2.64199744 |
| 57 | Gout (HP:0001997) | 2.61348137 |
| 58 | Abnormal ossification of hand bones (HP:0005921) | 2.55281065 |
| 59 | Abnormal hand bone ossification (HP:0010660) | 2.53947811 |
| 60 | Nephritis (HP:0000123) | 2.53726741 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.52465067 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 2.49498151 |
| 63 | Cholecystitis (HP:0001082) | 2.49498151 |
| 64 | Asymmetry of the thorax (HP:0001555) | 2.48305175 |
| 65 | Cholelithiasis (HP:0001081) | 2.47838563 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.46363466 |
| 67 | Facial shape deformation (HP:0011334) | 2.44747447 |
| 68 | Potter facies (HP:0002009) | 2.44747447 |
| 69 | Purpura (HP:0000979) | 2.44400259 |
| 70 | Small epiphyses (HP:0010585) | 2.43416915 |
| 71 | Lethargy (HP:0001254) | 2.42101038 |
| 72 | Mitral stenosis (HP:0001718) | 2.39159399 |
| 73 | Spastic diplegia (HP:0001264) | 2.38818623 |
| 74 | Neonatal onset (HP:0003623) | 2.38787284 |
| 75 | Irritability (HP:0000737) | 2.38592186 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37939185 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.37939185 |
| 78 | Glomerulonephritis (HP:0000099) | 2.35222851 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.35081084 |
| 80 | Broad palm (HP:0001169) | 2.34650855 |
| 81 | Vaginal fistula (HP:0004320) | 2.32309203 |
| 82 | Amyloidosis (HP:0011034) | 2.31800709 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 2.28889994 |
| 84 | Pigmentary retinal degeneration (HP:0001146) | 2.28619000 |
| 85 | Hepatoblastoma (HP:0002884) | 2.28205650 |
| 86 | Neonatal short-limb short stature (HP:0008921) | 2.22776990 |
| 87 | Late onset (HP:0003584) | 2.21007920 |
| 88 | Abnormality of the nasal septum (HP:0000419) | 2.18151678 |
| 89 | Abnormality of the lumbar spine (HP:0100712) | 2.17680302 |
| 90 | Osteomalacia (HP:0002749) | 2.14317077 |
| 91 | Poikilocytosis (HP:0004447) | 2.12679444 |
| 92 | Esophageal varix (HP:0002040) | 2.11696698 |
| 93 | Enlarged kidneys (HP:0000105) | 2.10899792 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 2.10663419 |
| 95 | Hemorrhage of the eye (HP:0011885) | 2.10184694 |
| 96 | Rickets (HP:0002748) | 2.09732059 |
| 97 | Wide cranial sutures (HP:0010537) | 2.07321156 |
| 98 | Increased serum pyruvate (HP:0003542) | 2.06776529 |
| 99 | Brushfield spots (HP:0001088) | 2.05882288 |
| 100 | Cerebral edema (HP:0002181) | 2.05360832 |
| 101 | Hypophosphatemic rickets (HP:0004912) | 2.05227180 |
| 102 | Pancreatitis (HP:0001733) | 2.04410377 |
| 103 | Alacrima (HP:0000522) | 2.03317683 |
| 104 | Gingival bleeding (HP:0000225) | 2.02491988 |
| 105 | Alkalosis (HP:0001948) | 2.02324833 |
| 106 | Vomiting (HP:0002013) | 2.00617454 |
| 107 | Abnormality of glycolysis (HP:0004366) | 2.00127317 |
| 108 | Hydroxyprolinuria (HP:0003080) | 2.00062561 |
| 109 | Abnormality of proline metabolism (HP:0010907) | 2.00062561 |
| 110 | Status epilepticus (HP:0002133) | 1.99871353 |
| 111 | Bronchomalacia (HP:0002780) | 1.99310634 |
| 112 | Abnormal foot bone ossification (HP:0010675) | 1.95912227 |
| 113 | Bifid scrotum (HP:0000048) | 1.94995848 |
| 114 | Opisthotonus (HP:0002179) | 1.94540028 |
| 115 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94099243 |
| 116 | Menorrhagia (HP:0000132) | 1.93477110 |
| 117 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93470122 |
| 118 | Thrombophlebitis (HP:0004418) | 1.92127925 |
| 119 | Protrusio acetabuli (HP:0003179) | 1.92037419 |
| 120 | Focal segmental glomerulosclerosis (HP:0000097) | 1.91359867 |
| 121 | Epiphyseal dysplasia (HP:0002656) | 1.89425387 |
| 122 | Glomerulosclerosis (HP:0000096) | 1.88497708 |
| 123 | Flared iliac wings (HP:0002869) | 1.86078341 |
| 124 | Arthropathy (HP:0003040) | 1.85490385 |
| 125 | Abnormal cartilage morphology (HP:0002763) | 1.85098023 |
| 126 | Hypotension (HP:0002615) | 1.84976953 |
| 127 | Abnormality of vitamin metabolism (HP:0100508) | 1.80859729 |
| 128 | Abnormality of the Achilles tendon (HP:0005109) | 1.80462552 |
| 129 | Neonatal death (HP:0003811) | 1.80385319 |
| 130 | Abnormality of the acetabulum (HP:0003170) | 1.80318496 |
| 131 | Reticulocytosis (HP:0001923) | 1.79645058 |
| 132 | Ileus (HP:0002595) | 1.79499435 |
| 133 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79096669 |
| 134 | Proximal tubulopathy (HP:0000114) | 1.76592024 |
| 135 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.76205316 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76086781 |
| 137 | Generalized aminoaciduria (HP:0002909) | 1.75254786 |
| 138 | Symptomatic seizures (HP:0011145) | 1.74249295 |
| 139 | Increased purine levels (HP:0004368) | 1.74197456 |
| 140 | Hyperuricemia (HP:0002149) | 1.74197456 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 1.72698039 |
| 142 | Cupped ribs (HP:0000887) | 1.69100137 |
| 143 | Impaired pain sensation (HP:0007328) | 1.68315707 |
| 144 | Abnormality of pain sensation (HP:0010832) | 1.68315707 |
| 145 | Irregular epiphyses (HP:0010582) | 1.66553013 |
| 146 | Abnormality of the vitreous humor (HP:0004327) | 1.65802018 |
| 147 | Hypophosphatemia (HP:0002148) | 1.60786911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.73288595 |
| 2 | SIK1 | 4.32536180 |
| 3 | FGFR4 | 4.31548854 |
| 4 | ERN1 | 4.18435317 |
| 5 | EPHA2 | 3.26921470 |
| 6 | WNK4 | 3.08340678 |
| 7 | ERBB4 | 2.89715014 |
| 8 | CDK12 | 2.78069296 |
| 9 | TAOK3 | 2.72903418 |
| 10 | INSRR | 2.70939626 |
| 11 | MST1R | 2.69818869 |
| 12 | MAP2K4 | 2.56319562 |
| 13 | PIK3CA | 2.31530992 |
| 14 | TYRO3 | 2.26494593 |
| 15 | PKN2 | 2.02982020 |
| 16 | DAPK2 | 1.95026234 |
| 17 | PTK6 | 1.86340479 |
| 18 | FRK | 1.73916453 |
| 19 | MAPK11 | 1.73867012 |
| 20 | DDR2 | 1.72678903 |
| 21 | FGFR1 | 1.67122786 |
| 22 | EEF2K | 1.62313815 |
| 23 | LATS1 | 1.60528793 |
| 24 | TRIB3 | 1.55783236 |
| 25 | FGFR2 | 1.48248772 |
| 26 | ERBB2 | 1.45205004 |
| 27 | WNK1 | 1.44579958 |
| 28 | MAP3K7 | 1.42823680 |
| 29 | ICK | 1.38995332 |
| 30 | PIK3CG | 1.38231399 |
| 31 | RIPK1 | 1.37142502 |
| 32 | AKT3 | 1.34201281 |
| 33 | MARK1 | 1.33444549 |
| 34 | STK39 | 1.28729351 |
| 35 | PRKCZ | 1.17917858 |
| 36 | GRK6 | 1.17379546 |
| 37 | PRKAA2 | 1.14260815 |
| 38 | MAP3K10 | 1.14217476 |
| 39 | EPHB2 | 1.12654136 |
| 40 | TYK2 | 1.08320721 |
| 41 | ABL2 | 1.07848782 |
| 42 | FLT3 | 1.06001876 |
| 43 | JAK2 | 1.05720464 |
| 44 | MAPK15 | 1.04690424 |
| 45 | PRKG2 | 1.02862820 |
| 46 | CDC42BPA | 0.96447946 |
| 47 | ACVR1B | 0.95031012 |
| 48 | EPHA4 | 0.93971740 |
| 49 | MET | 0.90284413 |
| 50 | SMG1 | 0.89864233 |
| 51 | EPHB1 | 0.87797068 |
| 52 | MAP2K6 | 0.87343985 |
| 53 | PRKAA1 | 0.86599323 |
| 54 | MAPK4 | 0.86340863 |
| 55 | PINK1 | 0.86025625 |
| 56 | PTK2 | 0.85435011 |
| 57 | IRAK3 | 0.84724166 |
| 58 | FGR | 0.81492161 |
| 59 | DYRK1B | 0.80873737 |
| 60 | PRKACG | 0.80280751 |
| 61 | SGK3 | 0.79817401 |
| 62 | CAMK1D | 0.79553144 |
| 63 | CAMK2G | 0.79263134 |
| 64 | MAPK12 | 0.77996105 |
| 65 | MAP3K4 | 0.73884630 |
| 66 | CAMK1G | 0.70920694 |
| 67 | GSK3A | 0.70423416 |
| 68 | JAK1 | 0.67837031 |
| 69 | CSNK1G2 | 0.67455519 |
| 70 | RET | 0.67247405 |
| 71 | PKN1 | 0.66512234 |
| 72 | CDK7 | 0.66446643 |
| 73 | LATS2 | 0.66312468 |
| 74 | TBK1 | 0.66089235 |
| 75 | MATK | 0.65753763 |
| 76 | CSNK1G1 | 0.63280825 |
| 77 | PDPK1 | 0.63235424 |
| 78 | PAK3 | 0.62383954 |
| 79 | NTRK3 | 0.61357052 |
| 80 | EPHA3 | 0.61333814 |
| 81 | NEK9 | 0.61187242 |
| 82 | SGK494 | 0.59049890 |
| 83 | SGK223 | 0.59049890 |
| 84 | NEK2 | 0.58581692 |
| 85 | PRKCG | 0.57845973 |
| 86 | SGK2 | 0.57713037 |
| 87 | KSR2 | 0.57369019 |
| 88 | CDK6 | 0.57243040 |
| 89 | MAP3K2 | 0.56642200 |
| 90 | KDR | 0.56140742 |
| 91 | STK38L | 0.55186265 |
| 92 | SGK1 | 0.55084345 |
| 93 | NTRK1 | 0.54729383 |
| 94 | SIK2 | 0.54313772 |
| 95 | MAP2K2 | 0.54118249 |
| 96 | EIF2AK1 | 0.53868346 |
| 97 | RPS6KB1 | 0.53375685 |
| 98 | BRD4 | 0.53021553 |
| 99 | MAP2K1 | 0.52741079 |
| 100 | MARK2 | 0.52576308 |
| 101 | CSNK1G3 | 0.48953989 |
| 102 | CSK | 0.48847063 |
| 103 | CAMK4 | 0.48700261 |
| 104 | CSNK1E | 0.47962056 |
| 105 | CAMKK1 | 0.47872018 |
| 106 | MAP3K1 | 0.47813655 |
| 107 | CSNK1A1L | 0.46793376 |
| 108 | MAP3K11 | 0.46614143 |
| 109 | SRC | 0.45511462 |
| 110 | LMTK2 | 0.44646447 |
| 111 | FGFR3 | 0.43428031 |
| 112 | NTRK2 | 0.43045468 |
| 113 | MAPK7 | 0.42592724 |
| 114 | BRSK1 | 0.42376727 |
| 115 | MTOR | 0.41470932 |
| 116 | MAP3K9 | 0.41470488 |
| 117 | PHKG2 | 0.40748989 |
| 118 | PHKG1 | 0.40748989 |
| 119 | STK38 | 0.40601097 |
| 120 | BCR | 0.40599245 |
| 121 | GRK1 | 0.40000447 |
| 122 | MAP2K3 | 0.38741388 |
| 123 | MAP3K6 | 0.37378664 |
| 124 | IGF1R | 0.35740460 |
| 125 | PRKCQ | 0.35057298 |
| 126 | CSF1R | 0.34921852 |
| 127 | PDK1 | 0.34905205 |
| 128 | PDGFRA | 0.34472988 |
| 129 | MAP3K13 | 0.34084890 |
| 130 | TAOK1 | 0.33377715 |
| 131 | MELK | 0.33274267 |
| 132 | PRKCA | 0.32632172 |
| 133 | PDGFRB | 0.32590290 |
| 134 | MAP3K3 | 0.32438827 |
| 135 | FER | 0.32098718 |
| 136 | CDK8 | 0.30402436 |
| 137 | BMX | 0.29783536 |
| 138 | CDK9 | 0.28498128 |
| 139 | CDK4 | 0.24793877 |
| 140 | RPS6KA3 | 0.23411456 |
| 141 | NME1 | 0.21495207 |
| 142 | PDK2 | 0.21184267 |
| 143 | CDK15 | 0.20012689 |
| 144 | MAPKAPK3 | 0.19841517 |
| 145 | TGFBR2 | 0.19649504 |
| 146 | FYN | 0.18180357 |
| 147 | MAPK3 | 0.17191858 |
| 148 | MAPK8 | 0.16873721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.40592347 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.62393039 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36570782 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25401220 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04608175 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72800792 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71564456 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62579022 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59725146 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43947628 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.42486582 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33086315 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.27400719 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21985310 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11421857 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 1.99545451 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.98885496 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89843861 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88281011 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86732379 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86505928 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82257374 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78153987 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74296921 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72722251 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.72696765 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66698493 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66000307 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65977663 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65700580 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61613858 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58700408 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51373053 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51297693 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50400800 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48259426 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46228267 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38534661 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35335997 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34334474 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32775395 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30771193 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.25683126 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24907713 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22085406 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20199530 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16325518 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14647433 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14139558 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12974232 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10956859 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10492875 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05671823 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94835592 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93462683 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86904000 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86111579 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.85412019 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83020520 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80765412 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79674060 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74403497 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69686438 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63430370 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62533937 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57513664 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56677302 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51757719 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49511141 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46884135 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44813928 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41979848 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41574227 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36831723 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.36047010 |
| 76 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.31385024 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31108991 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26884974 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.26835886 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.25440806 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23534954 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.22067031 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21671366 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20068228 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15949885 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13863566 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11537295 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.10550300 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.09173859 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06583618 |
| 91 | Adherens junction_Homo sapiens_hsa04520 | 0.05280503 |
| 92 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.03184519 |
| 93 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.02610678 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.02402324 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.01430565 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1996941 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1967851 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1901244 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1863791 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1821826 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | -0.1758462 |
| 102 | GABAergic synapse_Homo sapiens_hsa04727 | -0.1748813 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1553838 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | -0.1529683 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1407971 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1116172 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1081986 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0961147 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0880381 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0766742 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0675083 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0515477 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0322454 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0143986 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | -0.0049234 |

